| abstract |
A compound is provided that is useful as an agonist of MT1 and / or MT2 receptors. The inventors of the present have carried out studies on the agonists of the MT1 and / or MT2 receptors and have discovered that an indole carboxamide compound has agonist action of the MT1 and / or MT2 receptors, thereby completing the present invention The indole carboxamide compound of the present invention has the agonist action of MT1 and / or MT2 receptors, as well as a low CNS penetration and, therefore, can be used as an agent to prevent and / or treat urological diseases; in one embodiment, lower urinary tract symptoms; in another modality, symptom of urine accumulation, in another modality, urinary incontinence; still in another modality, stress urinary incontinence; and the like |